Driver seriously injured in rollover crash on Gilead Street in Hebron
A driver has serious injuries following a rollover crash on Gilead Street in Hebron Monday, state police said. State police ...
Gilead upped on HIV franchise; Merck downgraded on Keytruda LoE at Deutsche Bank
Deutsche Bank upgraded Gilead Sciences (NASDAQ:GILD) on Tuesday, citing the antiviral developer’s HIV treatment franchise, ...
Gilead Sciences, Inc. (GILD): Among Renaissance Technologies Portfolio’s Top Stock Picks
We recently published a list of Renaissance Technologies Portfolio: Top 10 Stock Picks. In this article, we are going to take ...
Gilead’s lenacapavir under priority review could revolutionise HIV PrEP
Gilead Sciences has announced that the US Food and Drug Administration (FDA) has accepted its New Drug Application ...
Medscape2h
Cardiovascular Risk Calculators Fail Women and Black Patients With HIV
A common CV risk factor calculator for patients with HIV underestimates risk for Black patients and women, while risk for ...
GlobalData on MSN5d
Gilead’s lenacapavir moves closer to FDA approval for HIV PrEP use
Lenacapavir is already approved under the name Sunlenca as an HIV treatment for patients resistant to other medication ...
Gilead Sciences Inc. stock outperforms competitors on strong trading day
This was the stock's third consecutive day of gains.
Assembly Biosciences and Gilead's genital herpes treatment gives positive results in early stage trial
Assembly Bio said that it plans to advance ABI-1179 directly into the Phase 1b portion of the study, which will include ...
Fintel on MSN5d
Deutsche Bank Upgrades Gilead Sciences (GILD)
Fintel reports that on February 18, 2025, Deutsche Bank upgraded their outlook for Gilead Sciences (NasdaqGS:GILD) from Hold ...
Insider2h
Reputation: Your Greatest Asset in Tough Economic Times
In these turblent economic times, your business reputation has never been more important and is in your control. Focusing on your greatest asset will not only safeguard your good name in ...